CrushSCI.com
108Average days
91Median days
47Fastest days
245Longest days
2912025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

121 days

SARS-CoV-2 and diabetes: a post-pandemic reappraisal

Authors
Noora Said; Ian Jones; Emily K. Anderson-Baucum; Carmella Evans-MolinaShow moreShow less
Affiliations
1. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA; 2. Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, USA; 3. Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, USA; 4. Department of Medicine, Indiana University School of Medicine, Indianapolis, USA; 5. Richard L. Roudebush VA Medical Center, Indianapolis, USAShow moreShow less
Source PDF DOI Publisher page
61 days

Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes

Authors
Ernesto Maddaloni; Samantha Pezzica; Rocco Amendolara; Silvia Sabatini; Gabriele Mocciaro; Guido Sebastiani; Luca D’Onofrio; Fabrizia Carli; Marta Tesi; Mara Suleiman; Luca Navarini; Laura Nigi; Caterina Formichi; Marta Vomero; Marco Minerba; Piero Marchetti; Francesco Dotta; Raffaella Buzzetti; Amalia GastaldelliShow moreShow less
Affiliations
1. Department of Experimental Medicine, Sapienza University, Rome, Italy; 2. Cardiometabolic Risk Unit, Institute of Clinical Physiology-National Research Council, Pisa, Italy; 3. Diabetes Research Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy; 4. Fondazione Umberto Di Mario ONLUS, Toscana Life Science, Siena, Italy; 5. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 6. Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; 7. Rheumatology and Clinical Immunology, Department of Medicine, University of Rome Campus Bio-Medico School of Medicine, Rome, Italy; 8. Tuscany Centre for Precision Medicine (CReMeP), Siena, ItalyShow moreShow less
Source PDF DOI Publisher page
91 days

Autoantibody screening in children who are first-degree relatives of individuals with type 1 diabetes in a sibling-dominant cohort in Turkey: a multicentre study on prevalence, determinants and post-screening parent–child anxiety

Authors
Uğur C. Yılmaz; Deniz Ö. Kızılay; Özlem K. Kurt; İlkay B. Balaban Berber; İrem Gökdemir; Aysun Ata; Deniz Erden; Elif G. Basa; Ömer F. Yalçın; Sevim Onguner; Hanife G. Balkı; Sirmen K. Çetin; Samim Özen; Günay Demir; Gamze Y. Baş; Mehmet Soylu; Ahmet Anık; Fatih Gürbüz; Korcan Demir; Özge Köprülü; Selda A. Altıncık; Berna E. Filibeli; Burcu Özbaran; Raika D. Onmuş; Damla GökşenShow moreShow less
Affiliations
1. Department of Pediatric Endocrinology and Diabetes, Ege University Faculty of Medicine, Izmir, Turkey; 2. Department of Pediatric Endocrinology, Adnan Menderes University Faculty of Medicine, Aydın, Turkey; 3. Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara, Turkey; 4. Department of Pediatric Endocrinology, Afyon Kocatepe University Faculty of Medicine, Afyonkarahisar, Turkey; 5. Department of Pediatric Endocrinology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey; 6. Department of Pediatric Endocrinology, Dr Behçet Uz Children’s Hospital, Izmir, Turkey; 7. Department of Pediatric Endocrinology, Pamukkale University Faculty of Medicine, Denizli, Turkey; 8. Department of Pediatric Endocrinology, Izmir City Hospital, Izmir, Turkey; 9. Department of Pediatric Endocrinology, Mugla Training and Research Hospital, Mugla, Turkey; 10. Department of Child and Adolescent Psychiatry, Ege University Faculty of Medicine, Izmir, Turkey; 11. Department of Medical Microbiology and Immunology, Ege University Faculty of Medicine, Izmir, Turkey; 12. Department of Public Health, Ege University Faculty of Medicine, Izmir, TurkeyShow moreShow less
Source PDF DOI Publisher page
112 days

Metabolic and vascular outcomes after transition to the MiniMed 780G system in adults ≥65 years with type 1 diabetes: a randomised, single-centre study

Authors
Bartłomiej Matejko; Katarzyna Cyranka; Paulina Suduł; Kamila Susuł; Jakub Krężel; Juliia Chernovol; Paweł Maga; Maciej T. Malecki; Tomasz KlupaShow moreShow less
Affiliations
1. Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland; 2. Unit of Psychodiabetology, Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland; 3. University Hospital in Krakow, Krakow, Poland; 4. Department of Psychiatry, Jagiellonian University Medical College, Krakow, Poland; 5. Clinical Department of Angiology, University Hospital in Krakow, Krakow, Poland; 6. Department of Angiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, PolandShow moreShow less
Source PDF DOI Publisher page
195 days

Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion

Authors
Chiara Saponaro; Monica Imbernon; Isaline Louvet; Eleonora Deligia; Shiqian Chen; Iona Davies; Ana Acosta-Montalvo; Maria Moreno-Lopez; Eve Wemelle; Lakshmi Kothegala; Begoña Porteiro; Florent Auger; Lorea Zubiaga; Nathalie Dellalau; Julien Thevenet; Markus Mühlemann; Gianni Pasquetti; Valery Gmyr; Frank W. Pfrieger; Ruben Nogueiras; Markus Schwaninger; Patrik Rorsman; Bart Staels; Julie Kerr-Conte; Claude Knauf; Ben Jones; François Pattou; Vincent Prevot; Caroline BonnerShow moreShow less
Affiliations
1. Univ. Lille, Inserm, CHU Lille, U1190, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France; 2. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 3. Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR_S 1172, European Genomic Institute for Diabetes, Lille, France; 4. Blizard Institute, Queen Mary University of London, London, UK; 5. Division of Diabetes, Endocrinology and Metabolism, Section of Investigative Medicine, Imperial College London, London, UK; 6. Inserm U1220, Institut de Recherche en Santé Digestive (IRSD), International Research Project (IRP), NeuroMicrobiota Lab, CHU Purpan, Toulouse, France; 7. Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK; 8. CIMUS, Universidade de Santiago de Compostela, Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; 9. Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain; 10. Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41, UMS 2014, PLBS, Lille, France; 11. Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France; 12. Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany; 13. Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011, European Genomic Institute for Diabetes, Lille, FranceShow moreShow less
Source PDF DOI Publisher page
57 days

Impacting lives of people with diabetes: lessons learnt in India may be applicable to other low- and middle-income countries

Authors
Viswanathan MohanShow moreShow less
Affiliations
1. Madras Diabetes Research Foundation (ICMR – Collaborating Centre of Excellence), Chennai, India; 2. Dr. Mohan’s Diabetes Specialities Centre (IDF Centre of Excellence in Diabetes Care), Chennai, IndiaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.